Month: March 2022

Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business Update

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

Alan Bash, experienced biopharmaceutical executive, appointed President and CEO Clinical trials with vidutolimod (CMP-001) in melanoma, head and neck cancer indications ongoing; Trial dosing initiated in cohorts for PD-1 refractory non-melanoma skin cancers Preliminary clinical data readouts anticipated in second half of 2022 CAMBRIDGE, Mass., March 29, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced full year 2021 financial results and provided a business update. “Our vidutolimod program continued to advance in 2021 and expand into multiple cancer indications,” said Alan Bash, President and Chief Executive Officer of Checkmate....

Fortress Transportation and Infrastructure Investors LLC Announces Timing of First Quarter Earnings and Conference Call

Written by Customer Service on March 29, 2022. Posted in Public Companies.

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI; the “Company”) plans to announce its financial results for the first quarter 2022 after the closing of the New York Stock Exchange on Thursday, April 28, 2022. A copy of the press release and an earnings supplement will be posted to the Investor Relations section of the Company’s website, www.ftandi.com. In addition, management will host a conference call on Friday, April 29, 2022 at 8:00 A.M. Eastern Time. The conference call may be accessed by dialing (877) 447-5636 (from within the U.S.) or (615) 247-0080 (from outside of the U.S.) ten minutes prior to the scheduled start of the call; please reference “FTAI First Quarter 2022 Earnings Call.” A simultaneous webcast of the conference call...

Concentrix Reports First Quarter 2022 Results

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

NEWARK, Calif., March 29, 2022 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a leading global provider of customer experience (CX) solutions and technology, today announced financial results for the fiscal first quarter ended February 28, 2022. Three Months Ended February 28, 2022 February 28, 2021 ChangeRevenue($M) $ 1,536.1 $ 1,353.3 13.5 %Operating income($M) $ 147.7 $ 134.9 9.5 %Non-GAAP operating income($M)(1) $ 201.9 $ 176.6 14.3 %Operating margin 9.6 % 10.0 % -40 bpsNon-GAAP operating margin(1) 13.1 % 13.1 % 0 bpsNet income($M) $ 110.3 $ 88.8 24.2 %Non-GAAP net income($M)(1) $ 150.7 $ 120.0 25.6 %Adjusted EBITDA($M)(1) $ 237.9 $ 212.6 11.9 %Adjusted EBITDA margin(1) 15.5 % 15.7 % -20 bpsDiluted...

Progress Announces First Quarter 2022 Financial Results

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

Revenue and Earnings Per Share Exceed Guidance Ranges Full Year Guidance Increased for Revenue and Earnings Per Share BEDFORD, Mass., March 29, 2022 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of infrastructure software, today announced financial results for its fiscal first quarter ended February 28, 2022. First Quarter 2022 Highlights:Revenue of $144.9 million increased 19% year-over-year on an actual currency basis, and 21% on a constant currency basis. Non-GAAP revenue of $147.5 million increased 12% on an actual currency basis, and 14% on a constant currency basis. Annualized Recurring Revenue (ARR) of $479 million increased 12% year-over-year on a constant currency basis. Operating margin was 20% and Non-GAAP operating margin was 40%. Diluted earnings per share was $0.46 compared to $0.42 in the same...

Omega Flex, Inc. Announces Regular Quarterly Dividend for the First Quarter 2022

Written by Customer Service on March 29, 2022. Posted in Dividend Reports And Estimates.

EXTON, Pa., March 29, 2022 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.30 per share payable on April 25, 2022, to shareholders of record on April 11, 2022. Kevin R. Hoben, the Company’s chairman stated that: “The commitment of Omega Flex, Inc. to its shareholders is reflected in part by the payment of this regular quarterly dividend. As the Company continues to emerge from this challenging time for the country and the economy, this dividend is the best indication of our belief in the Company’s ability to weather this storm.” In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans,...

SomaLogic Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

Fourth quarter 2021 revenue of $23.0 million contributed to record full year revenue of $81.6 million, 46% growth over the prior year Established over 75 new customer accounts, expanding and diversifying revenue base Substantial cash and investments of $657.7 million at year-end Maintaining 2022 full year revenue guidance of $105-110 million Management to host conference call today at 4:30pm ETBOULDER, Colo., March 29, 2022 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter and year ended December 31, 2021. “2021 was a transformational year for SomaLogic, and we see a long runway to continue executing on our growth plan ahead,” said Roy Smythe, M.D., SomaLogic’s Chief Executive Officer. “Twenty years of research and innovation have culminated...

Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2022

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

Delivers strong profitability and over $1 billion in free cash flow BOISE, Idaho, March 29, 2022 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced results for its second quarter of fiscal 2022, which ended March 3, 2022. Fiscal Q2 2022 highlightsRevenue of $7.79 billion versus $7.69 billion for the prior quarter and $6.24 billion for the same period last year GAAP net income of $2.26 billion, or $2.00 per diluted share Non-GAAP net income of $2.44 billion, or $2.14 per diluted share Operating cash flow of $3.63 billion versus $3.94 billion for the prior quarter and $3.06 billion for the same period last year“Micron’s excellent second quarter results exceeded the high end of our guidance for both revenue and margin, reflecting our strong execution,” said Micron Technology President and CEO Sanjay Mehrotra....

Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

Received FDA clearance in February 2022 to market Pure-Vu EVS, an all new, next-generation system that has been deployed to multiple hospitals in the first few weeks since launchDoubled the size of the sales team since November, and plan to continue investing in commercial expansion throughout 2022Advancing strategy to secure reimbursement for the Pure-Vu System for certain outpatient colonoscopies, targeting ~4.7M outpatient procedures per year in the U.S.FORT LAUDERDALE, Fla., March 29, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today reported its...

OpGen Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

Total revenue for 2021 was approximately $4.3 million Strong total cash position of approximately $36.1 million as of December 31, 2021, up significantly from $13.4 million at year-end 2020 Conference call to be held March 29, 2022 at 4:30 p.m. EDTROCKVILLE, Md., March 29, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported today its fourth quarter 2021 and full-year 2021 financial and operating results and provided a business update. OpGen’s revenue for the fourth quarter of 2021 was approximately $1.43 million, a 5% increase from $1.35 million in Q4 2020. Its total revenue for 2021 was approximately $4.3 million, up 2% from $4.2 million in 2020. “We are pleased...

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 29, 2022. Posted in Earnings Releases And Operating Results.

REDWOOD CITY, Calif., March 29, 2022 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a business update. “2022 is on track to be an important year for Adverum, as we progress our plan to initiate a Phase 2 trial evaluating two doses of ADVM-022 in patients with wet age-related macular degeneration,” stated Laurent Fischer, M.D., president and chief executive officer at Adverum Biotechnologies. “Given our robust safety review of all 55 patients treated with ADVM-022, promising clinical efficacy data generated in our OPTIC study in wet age-related macular degeneration and cash runway into 2024, we are able to approach...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals